The Authors' reply
- Matthew E Harinstein1,
- James D Flaherty2,
- Andrew P Ambrosy3,
- Gregg C Fonarow4,
- Robert O Bonow2,5,
- Mihai Gheorghiade2,5
- 1Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
- 2Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- 3Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
- 4Department of Medicine, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California, USA
- 5Department of Medicine, Section of Experimental Therapeutics, Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Correspondence to Professor Mihai Gheorghiade, Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, 645N. Michigan Avenue, Suite 1006, Chicago, IL 60611, USA; m-gheorghiade{at}northwestern.edu
-
Contributors All authors contributed equally to this letter.
The Authors' reply We appreciate the comments and viewpoints of Dr Basu1 regarding our paper detailing the clinical assessment of patients initially presenting to the emergency department with acute heart failure syndromes (AHFS) through hospitalisation and the early post-discharge period.2
We agree with Dr Basu regarding the important role that blood pressure (BP) plays in the pathophysiology and, consequently, the comprehensive clinical assessment of AHFS.3 The Organised Program to Initiate Lifesaving Treatment in Hospitalised Patients with Heart Failure (OPTIMISE-HF) …








